Sagamore Bioventures

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 8, 2015	ASLAN Pharmaceuticals	$34.0M Series C	Accuron Technologies	Bioveda Ventures, Cenova Capital, Haitong International, Morningside, Tianda Pharmaceuticals

Total Raised

N/A

Valuation

N/A